{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2025.08.08.25333050v1\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2025.08.08.25333050v1\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2025.08.08.25333050v1\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-2\u0022\u003EThe \u003Cem\u003EC9orf72\u003C\/em\u003E hexanucleotide repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). In genetic counselling, children of mutation carriers are often told that they have a 50% risk of carrying the mutation, but this figure does not take into account the fact that penetrance is age-related, with a unimodal distribution of disease onset around 58 years of age. Using a Bayesian approach, we developed a theory to calculate the probability of carrying the mutation for asymptomatic relatives (children\/siblings and grandchildren\/niblings) as well as the probability of developing ALS\/FDT within a given time frame, based on their age. Using published data on age-related penetrance, we then calculated these probabilities and developed an online simulator that makes it easy to calculate them on a case-by-case basis. The probabilities obtained can be very different from Mendelian values. For example, a 70-year-old asymptomatic child born to a carrier has approximately a 6% risk of being a carrier, which is far from 50%. For grandchildren, taking into account both their age and that of their parents also leads to figures that are much lower than those obtained if only their age were considered. For consultands, the decision to undergo testing is based in part on risk estimates. In this regard, the refined estimates and simulator we propose may prove to be valuable tools for genetic counselling for families affected by ALS\/FTD linked to the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E mutation. In addition, the formulas used in this study could also be used to calculate risk estimates for other diseases caused by autosomal dominant mutations with age-dependent penetrance.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EIntroduction\u003C\/h2\u003E\u003Cp id=\u0022p-15\u0022\u003EAmyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative diseases primarily characterized by motor and behavioral dysfunction, respectively [\u003Ca id=\u0022xref-ref-17-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-17\u0022\u003E17\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E]. Both conditions have been genetically linked to the mutation \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E, a hexanucleotide repeat expansion in the \u003Cem\u003EC9orf72\u003C\/em\u003E gene, which is the most common genetic cause of ALS (34.2%) and FTD (25.2% of the cases [\u003Ca id=\u0022xref-ref-4-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-18-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-3-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E]). This mutation being autosomal and dominant, the children and siblings of an affected individual have, \u003Cem\u003Ea priori\u003C\/em\u003E, 50% risk of being carrier of the mutation, whereas the grandchildren and niblings (nieces and nephews) have a 25% risk. Molecular genetic testing can confirm the genetic origin of ALS\/FTD in affected individuals, and can also be used to identify carriers of the mutation among relatives. However, the choice for relatives to be tested or not is far from trivial, and should be based not only on a thorough clinical assessment [\u003Ca id=\u0022xref-ref-10-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E], but also on a precise estimate of the risks.\u003C\/p\u003E\u003Cp id=\u0022p-16\u0022\u003EThe standard probability of 0.5 and 0.25 assigned respectively to children\/siblings and grandchildren\/niblings eligible for testing does not take into account the age of the consultands. However, the penetrance is clearly age-dependent, with a distribution of the age of onset of symptoms centred around 58 years [\u003Ca id=\u0022xref-ref-10-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-14-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E], so that the probability of unaffected individuals to be carrier of the mutation decreases with age, and the probability of developing the disease in the future drops rapidly once the median age of symptom onset has been exceeded.\u003C\/p\u003E\u003Cp id=\u0022p-17\u0022\u003EIn this article, we use a Bayesian approach to estimate age-specific probabilities of carrying a mutation and developing the associated disease later in life for the relatives of a carrier of an autosomal dominant mutation. We derived these probabilities in the case of both complete penetrance of the mutation with age and incomplete penetrance, \u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E., when a fraction of carriers is assumed to never develop the disease.\u003C\/p\u003E\u003Cp id=\u0022p-18\u0022\u003EWe applied these developments to the data on age-related penetrance of \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E from the large cohort of Murphy et al. [\u003Ca id=\u0022xref-ref-14-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E], and provided numerical estimates of these probabilities. Our results show that the risks of being a carrier of the variant and of developing the disease over time can deviate in a large extent from the naive Mendelian proportions usually given to the consultands. For example, in the case of complete penetrance with age, a child presenting no symptoms at the age of 70 would have a risk of about 6% of being a carrier of the mutation (instead of 50%) and a 5.5% risk of developing the disease in the following 10 years. If 20% of carriers are non-penetrant, the risk of being carrier rises to about 20%, still well below 50%, but the risk of developing the disease in the next 10 years falls to about 4%.\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003EThese results are integrated into a practical online simulator designed for genetic counsellors, providing them with reliable risk estimates. This can help them meet the expectations of consultands who need as much information as possible to decide whether they wish to undergo testing for \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E. The methodology presented could also be applied to any disease caused by autosomal dominant mutations, after implementation of available age-related penetrance data.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cdiv id=\u0022sec-3\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ETheoretical developments\u003C\/h3\u003E\u003Cp id=\u0022p-20\u0022\u003EWe addressed two linked questions regarding the unaffected relatives of carriers of autosomal dominant mutations that have age-dependant penetrance: (i) what is the probability of being carrier of the mutation? (ii) what is the probability of developing the disease over the next \u003Cem\u003En\u003C\/em\u003E years? We considered either that penetrance tends towards 1 with age, or that there is a fraction \u003Cem\u003Ex\u003C\/em\u003E of carriers who never develop symptoms, \u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E., who are \u201cnon-penetrant\u201d carriers, a supposedly non-heritable characteristic. (see Discussion). The equations we obtained using a Bayesian framework are summarised in \u003Ca id=\u0022xref-table-wrap-1-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E, which offers a comprehensive overview of the probabilities useful in genetic counselling for the children and grandchildren of a mutation carrier (see detailed mathematical developments in the Appendix). For simplicity, we only mention below children and grandchildren, but the results apply as such to siblings and niblings, respectively, because they have the same Mendelian probabilities of inheriting the mutation. Among the eight equations of \u003Ca id=\u0022xref-table-wrap-1-2\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E, only \u003Ca id=\u0022xref-disp-formula-4-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-4\u0022\u003Eequations 2\u003C\/a\u003E and \u003Ca id=\u0022xref-disp-formula-12-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-12\u0022\u003E8\u003C\/a\u003E had previously been established [\u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-16-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E], but to our knowledge, they have remained unexploited to this day for genetic counselling. The probabilities are quite simple functions of the age-related penetrance \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E (or \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-1\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-1.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-1.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, with a similar structure of the equations in columns \u2018Child\u2019 and \u2018Grandchild\u2019: there is just one additional term in the equations relating to grandchildren, which is the inverse of the probability of being a carrier for the grandchild\u2019s parent (the child).\u003C\/p\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/1046036\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/1046036\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/1046036\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 1:\u003C\/span\u003E \u003Cp id=\u0022p-21\u0022 class=\u0022first-child\u0022\u003EFormulae to be used for computing the risk probabilities for non-affected relatives of a carrier of an autosomal dominant mutation. The penetrance at age \u003Cem\u003Et\u003C\/em\u003E is denoted \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E. \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-2\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/T1\/embed\/inline-graphic-2.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/T1\/embed\/inline-graphic-2.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E is the penetrance at age \u003Cem\u003Et\u003C\/em\u003E when a fraction \u003Cem\u003Ex\u003C\/em\u003E of the carriers never get affected. \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E1\u003C\/sub\u003E and \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E2\u003C\/sub\u003E are the ages of the child and the grandchild, respectively. The numbers in parentheses correspond to the equation numbers in the Appendix. *The equations of this column are also valid for the siblings of the carrier. **The equations of this column are also valid for the niblings (nieces and nephews) of the carrier.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EProbability estimates from empirical data on \u003Cem\u003EC9orf72\u003C\/em\u003E\u003Csup\u003ERE\u003C\/sup\u003E penetrance\u003C\/h3\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EDataset description\u003C\/h4\u003E\u003Cp id=\u0022p-22\u0022\u003EUsing the equations presented in \u003Ca id=\u0022xref-table-wrap-1-3\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E, we computed the age-dependent probabilities of (i) carrying the variant \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E and (ii) developing ALS\/FTD symptoms, taking advantage of the agedependent penetrance data from [\u003Ca id=\u0022xref-ref-14-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E] that are based on a cohort of 1169 individuals carrying the mutation. Among these individuals, 1146 had FTD and\/or ALS symptoms, with age at symptom onset varying from 25 to 83 (\u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 1A\u003C\/a\u003E), and 23 were asymptomatic. We discarded these asymptomatic cases as they do not inform us on the actual fraction of non-penetrant carriers in the population, for two reasons: first, a certain proportion of them, if not all, may end up developing the disease; second, if they are real non-penetrant carriers, their number might be underestimated as healthy individuals are less likely to consult and undergo genetic testing. Using the 1146 symptomatic individuals we got an estimate of the age-related penetrance \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E by dividing the cumulative count at each age by the total number of individuals (\u003Ca id=\u0022xref-fig-1-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 1B\u003C\/a\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Distribution of age at onset of symptoms in 1146 individuals carrying the C9orf72 RE mutation (A) and corresponding age-dependent penetrance of the mutation (B). Data from [14].\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1526367179\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;Distribution of age at onset of symptoms in 1146 individuals carrying the \u0026lt;em\u0026gt;C9orf72\u0026lt;\/em\u0026gt; \u0026lt;sup\u0026gt;RE\u0026lt;\/sup\u0026gt; mutation (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) and corresponding age-dependent penetrance of the mutation (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;). Data from [14].\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 1:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022251\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 1:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022251\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1:\u003C\/span\u003E \u003Cp id=\u0022p-23\u0022 class=\u0022first-child\u0022\u003EDistribution of age at onset of symptoms in 1146 individuals carrying the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E mutation (\u003Cstrong\u003EA\u003C\/strong\u003E) and corresponding age-dependent penetrance of the mutation (\u003Cstrong\u003EB\u003C\/strong\u003E). Data from [\u003Ca id=\u0022xref-ref-14-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E].\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch4\u003EAge-dependent probability of carrying the mutation\u003C\/h4\u003E\u003Cp id=\u0022p-24\u0022\u003EWe used equation \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-3\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-3.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-3.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-4-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-4\u0022\u003Eequation 2\u003C\/a\u003E in \u003Ca id=\u0022xref-table-wrap-1-4\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E) to estimate the probability of asymp-tomatic children to carry the mutation, given their age (\u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2A\u003C\/a\u003E, dark blue curve). This estimate is very close to 0.5 at age 25-30, then decreases to 0.27 at age 60 and 0.06 at age 70. So the risk of carrying the variant for healthy individuals is very dependent on their age and can be far from the 50% risk commonly communicated to the consultands for this disease (\u003Ca id=\u0022xref-fig-2-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2A\u003C\/a\u003E, dashed grey line).\u003C\/p\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Age-related risk estimates for asymptomatic child and grandchild of a carrier of the C9orf72 RE mutation. A. Relationship between age and the probability of being carrier for an asymptomatic child, assuming that the fraction of non-penetrant carriers is either x = 0 (dark blue curve) or x = 0.2 (light blue curve). B. Same relationships for a grandchild of the carrier, in the case where the age difference between the child and the grandchild is 25 years (solid lines) or 35 years (dotted curves). Color codes: same as in A.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1526367179\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;Age-related risk estimates for asymptomatic child and grandchild of a carrier of the \u0026lt;em\u0026gt;C9orf72\u0026lt;\/em\u0026gt; \u0026lt;sup\u0026gt;RE\u0026lt;\/sup\u0026gt; mutation. \u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;. Relationship between age and the probability of being carrier for an asymptomatic child, assuming that the fraction of non-penetrant carriers is either \u0026lt;em\u0026gt;x\u0026lt;\/em\u0026gt; = 0 (dark blue curve) or \u0026lt;em\u0026gt;x\u0026lt;\/em\u0026gt; = 0.2 (light blue curve). \u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;. Same relationships for a grandchild of the carrier, in the case where the age difference between the child and the grandchild is 25 years (solid lines) or 35 years (dotted curves). Color codes: same as in \u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 2:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022253\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 2:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F2.medium.gif\u0022 width=\u0022440\u0022 height=\u0022253\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 2:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 2:\u003C\/span\u003E \u003Cp id=\u0022p-25\u0022 class=\u0022first-child\u0022\u003EAge-related risk estimates for asymptomatic child and grandchild of a carrier of the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E mutation. \u003Cstrong\u003EA\u003C\/strong\u003E. Relationship between age and the probability of being carrier for an asymptomatic child, assuming that the fraction of non-penetrant carriers is either \u003Cem\u003Ex\u003C\/em\u003E = 0 (dark blue curve) or \u003Cem\u003Ex\u003C\/em\u003E = 0.2 (light blue curve). \u003Cstrong\u003EB\u003C\/strong\u003E. Same relationships for a grandchild of the carrier, in the case where the age difference between the child and the grandchild is 25 years (solid lines) or 35 years (dotted curves). Color codes: same as in \u003Cstrong\u003EA\u003C\/strong\u003E.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-26\u0022\u003EIf a fraction \u003Cem\u003Ex\u003C\/em\u003E of the population is non affected by the mutation irrespective of age, the probability of carrying the mutation is given by equation \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-4\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-4.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-4.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-6-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-6\u0022\u003Eequation 4\u003C\/a\u003E) (\u003Ca id=\u0022xref-fig-2-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2A\u003C\/a\u003E, light blue curve). This probability increases with the fraction of non-penetrant carriers, reaching the maximum probability of 0.5, regardless of age, in the unrealistic assumption where 100% of carriers were nonpenetrant (\u003Cem\u003Ex\u003C\/em\u003E = 1). This reflects the fact that being unaffected at a given age is less and less informative as \u003Cem\u003Ex\u003C\/em\u003E increases.\u003C\/p\u003E\u003Cp id=\u0022p-27\u0022\u003EThese probabilities can also be calculated for the carrier\u2019s grandchildren, when their parent (the carrier\u2019s child) is not affected and their carrier status is unknown. If \u003Cem\u003Ex\u003C\/em\u003E = 0, the probability of being carrier is \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-5\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-5.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-5.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-19-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-19\u0022\u003Eequation 11\u003C\/a\u003E), which depends on both the age of the grandchildren and the age of their parent (\u003Ca id=\u0022xref-fig-2-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2B\u003C\/a\u003E, dark blue curve). For instance, if a grandchild is 45 and its parent (child of the carrier) is 70 (\u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee. \u03b4\u003C\/em\u003E, the age difference between both, is 25 years), the probability is 0.025, a value ten times lower than the prior probability of 0.25 for grandchildren to carry the mutation in the absence of information regarding the age-dependent penetrance.\u003C\/p\u003E\u003Cp id=\u0022p-28\u0022\u003EIf \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0, this probability is \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-6\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-6.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-6.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-22-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-22\u0022\u003Eequation 13\u003C\/a\u003E). With \u003Cem\u003Ex\u003C\/em\u003E = 0.2, the probability for the same 45-year old grandchild rises to 0.09 (\u003Ca id=\u0022xref-fig-2-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2B\u003C\/a\u003E, light blue curve). Indeed, for the reason mentioned above, the larger the \u003Cem\u003Ex\u003C\/em\u003E, the higher the probability of being a carrier. Consistently, in the theoretical case where \u003Cem\u003Ex\u003C\/em\u003E would be equal to 1 (\u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E. the penetrance is null), the limit would be 0.25, which is the prior Mendelian probability of being carrier for a grandchild (\u003Ca id=\u0022xref-fig-2-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2B\u003C\/a\u003E, dashed grey line).\u003C\/p\u003E\u003Cp id=\u0022p-29\u0022\u003EIf the age difference between the child and the grandchild is higher, the probability curves are shifted to the left. The probability of carrying the variant is lower since the unaffected child is older and has a lower probability of being a carrier. For example, with \u003Cem\u003E\u03b4\u003C\/em\u003E = 35 years, the 45-year old grandchild has a probability of being carrier of 0.07% if \u003Cem\u003Ex\u003C\/em\u003E = 0 and 7.6% if \u003Cem\u003Ex\u003C\/em\u003E = 0.2 (\u003Ca id=\u0022xref-fig-2-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2B\u003C\/a\u003E, dark and light blue dotted curves), to be compared to 2.5% and 9.1%, respectively, when \u003Cem\u003E\u03b4\u003C\/em\u003E = 25 years (\u003Ca id=\u0022xref-fig-2-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 2B\u003C\/a\u003E, dark and light blue solid curves).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EAge-dependent probability of developing the disease at a later age\u003C\/h3\u003E\u003Cp id=\u0022p-30\u0022\u003EThe probability that a child aged \u003Cem\u003Et\u003C\/em\u003E years will develop the disease over the next \u003Cem\u003En\u003C\/em\u003E years is \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-7\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-7.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-7.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-12-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-12\u0022\u003Eequation 8\u003C\/a\u003E). By setting \u003Cem\u003En\u003C\/em\u003E = 10 years, we observe that the probability is null up to age 20, then increases to reach a maximum of 0.26 at age 55, and then drops to 0 at age 80 (\u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 3A\u003C\/a\u003E, red curve). If we consider a longer-term risk, for example for \u003Cem\u003En\u003C\/em\u003E = 20 years (\u003Ca id=\u0022xref-fig-3-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 3C\u003C\/a\u003E, red curve), the maximum probability of declaring the disease is higher (0.4) and occurs for a younger age (51 years). Note that as \u003Cem\u003En\u003C\/em\u003E increases, the probability tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-8\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-8.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-8.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the probability of carrying the variant, which is consistent.\u003C\/p\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Age-related estimates for asymptomatic children (A and C) and grandchildren (B and D) of the risk of developing the disease in the next n = 10 years (A and B) or n = 20 years (C and D). In each plot, the relationship between the age and the probability to develop the disease is displayed for a fraction of non-penetrant carriers equal to x = 0 (red curve) or x = 0.2 (orange curve). For the grandchild risk estimates, the relationship is given for two different age differences to their relative (child of the carrier) : \u0026#x3B4; = 25 years (solid lines) or \u0026#x3B4; = 35 years (dotted lines).\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1526367179\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;Age-related estimates for asymptomatic children (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt; and \u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) and grandchildren (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt; and \u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;) of the risk of developing the disease in the next \u0026lt;em\u0026gt;n\u0026lt;\/em\u0026gt; = 10 years (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt; and \u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) or \u0026lt;em\u0026gt;n\u0026lt;\/em\u0026gt; = 20 years (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt; and \u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;). In each plot, the relationship between the age and the probability to develop the disease is displayed for a fraction of non-penetrant carriers equal to \u0026lt;em\u0026gt;x\u0026lt;\/em\u0026gt; = 0 (red curve) or \u0026lt;em\u0026gt;x\u0026lt;\/em\u0026gt; = 0.2 (orange curve). For the grandchild risk estimates, the relationship is given for two different age differences to their relative (child of the carrier) : \u0026lt;em\u0026gt;\u0026#x3B4;\u0026lt;\/em\u0026gt; = 25 years (solid lines) or \u0026lt;em\u0026gt;\u0026#x3B4;\u0026lt;\/em\u0026gt; = 35 years (dotted lines).\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 3:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F3.medium.gif\u0022 width=\u0022438\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 3:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F3.medium.gif\u0022 width=\u0022438\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 3:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 3:\u003C\/span\u003E \u003Cp id=\u0022p-31\u0022 class=\u0022first-child\u0022\u003EAge-related estimates for asymptomatic children (\u003Cstrong\u003EA\u003C\/strong\u003E and \u003Cstrong\u003EC\u003C\/strong\u003E) and grandchildren (\u003Cstrong\u003EB\u003C\/strong\u003E and \u003Cstrong\u003ED\u003C\/strong\u003E) of the risk of developing the disease in the next \u003Cem\u003En\u003C\/em\u003E = 10 years (\u003Cstrong\u003EA\u003C\/strong\u003E and \u003Cstrong\u003EB\u003C\/strong\u003E) or \u003Cem\u003En\u003C\/em\u003E = 20 years (\u003Cstrong\u003EC\u003C\/strong\u003E and \u003Cstrong\u003ED\u003C\/strong\u003E). In each plot, the relationship between the age and the probability to develop the disease is displayed for a fraction of non-penetrant carriers equal to \u003Cem\u003Ex\u003C\/em\u003E = 0 (red curve) or \u003Cem\u003Ex\u003C\/em\u003E = 0.2 (orange curve). For the grandchild risk estimates, the relationship is given for two different age differences to their relative (child of the carrier) : \u003Cem\u003E\u03b4\u003C\/em\u003E = 25 years (solid lines) or \u003Cem\u003E\u03b4\u003C\/em\u003E = 35 years (dotted lines).\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-32\u0022\u003EIf the penetrance is incomplete, the probability of declaring the disease is \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-9\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-9.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-9.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-17-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-17\u0022\u003Eequation 9\u003C\/a\u003E). The derivative of this function with respect to \u003Cem\u003Ex\u003C\/em\u003E is negative. So, whatever \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E and \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E, the probability of declaring the disease decreases as \u003Cem\u003Ex\u003C\/em\u003E increases (\u003Ca id=\u0022xref-fig-3-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 3A\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E3C\u003C\/a\u003E, orange curves), even though the probability of carrying the mutation increases.\u003C\/p\u003E\u003Cp id=\u0022p-33\u0022\u003EFor the grandchildren, we have \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-10\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-10.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-10.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-24-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-24\u0022\u003Eequation 15\u003C\/a\u003E), a probability much lower than that calculated for children at \u003Cem\u003En\u003C\/em\u003E = 10 years (\u003Ca id=\u0022xref-fig-3-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 3B\u003C\/a\u003E, red curve). When \u003Cem\u003En\u003C\/em\u003E increases, this probability tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-11\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-11.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-11.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the probability of carrying the mutation. If \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0, we have \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-12\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-12.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-12.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E (\u003Ca id=\u0022xref-disp-formula-29-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-29\u0022\u003Eequation 16\u003C\/a\u003E), which tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-13\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-13.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-13.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E as \u003Cem\u003En\u003C\/em\u003E increases.\u003C\/p\u003E\u003Cp id=\u0022p-34\u0022\u003E\u003Ca id=\u0022xref-disp-formula-29-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-29\u0022\u003EEquation 16\u003C\/a\u003E has a negative second derivative with respect to \u003Cem\u003Ex\u003C\/em\u003E, meaning that there is a value of \u003Cem\u003Ex\u003C\/em\u003E that maximises the probability of developing the disease. We show in the Appendix that this value, noted \u003Cem\u003Ex\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Em\u003C\/em\u003E\u003C\/sub\u003E, only depends on \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-14\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-14.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-14.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the age-dependent penetrance of the child. When \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-15\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-15.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-15.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, corresponding to 59 years of age or younger, \u003Cem\u003Ex\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Em\u003C\/em\u003E\u003C\/sub\u003E = 0. The fact that the probability of declaring the diseases for a grandchild is the highest when the penetrance is complete was expected. However, when \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-16\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-16.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-16.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, we show that \u003Cem\u003Ex\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Em\u003C\/em\u003E\u003C\/sub\u003E \u003Cem\u003E\u0026gt;\u003C\/em\u003E 0, with the upper limit \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-17\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-17.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-17.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. This means that the probability of declaring the disease is higher when there are non-penetrant carriers. This seemingly paradoxical result can be understood in the following way. Given that the children concerned have adult descendants, they are necessarily relatively elderly individuals. When \u003Cem\u003Ex\u003C\/em\u003E = 0, such unaffected child are very likely not carrier of the mutation, so the probability that their descendants (grandchildren) will develop the disease is negligible. When \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0, an elderly person may not be affected either because they are not a carrier or because they are a non-penetrant carrier. In the latter case, grandchildren may inherit the mutation and develop the disease if they belong to the (1\u003Cem\u003E\u2212x\u003C\/em\u003E) fraction of carriers. In any case, we see that the probability of developing the disease remains quite low for the grandchildren whose parent is unaffected (\u003Ca id=\u0022xref-fig-3-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 3B\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-3-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003ED\u003C\/a\u003E, orange curves).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-8\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EAn online simulator for genetic counselling\u003C\/h3\u003E\u003Cp id=\u0022p-35\u0022\u003EBased on the equations presented in \u003Ca id=\u0022xref-table-wrap-1-5\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E and Murphy et al.\u2019s data [\u003Ca id=\u0022xref-ref-14-5\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E], we developed an online simulator to easily estimate the risks of (i) carrying the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E variant and (ii) developing the disease (ALS or DFT) in the next \u003Cem\u003En\u003C\/em\u003E years. This tool, available free of charge online at \u003Ca href=\u0022https:\/\/lbbeshiny.univ-lyon1.fr\/ftd-als\/\u0022\u003Ehttps:\/\/lbbeshiny.univ-lyon1.fr\/ftd-als\/\u003C\/a\u003E, is designed to facilitate genetic counselling provided by professionals to consultands, with an interactive and intuitive way to compute the risk estimates. The tool is organised in three panels (\u003Ca id=\u0022xref-fig-4-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003E\u003Cstrong\u003EFigure\u003C\/strong\u003E 4\u003C\/a\u003E). In the left-hand panel, the input parameters can be set: age of the consultand, relationship to the affected individual (child\/sibling or grandchild\/nibling), age, age of its parent (when the consultand is a grandchild or a nibling), assumed disease penetrance, and time frame to compute the risk of declaring the disease. In the middle panel, the distributions of the probability to carry the mutation and the probability to declare the disease are plotted as a function of age, and the age of the consultand is highlighted by a dotted vertical line. In the right-hand panel, a summary of all the information is provided, along with the option to download a one-page pdf file.\u003C\/p\u003E\u003Cdiv id=\u0022F4\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F4.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Interface of the web-based tool for genetic counselling for the C9orf72 RE-related ALS\/FTD diseases, avaiblable at https:\/\/lbbe-shiny.univ-lyon1.fr\/ftd-als\/. The application includes three panels. Left: input of consultand\u0026#x2019;s information; Centre: graphical visualization of the age-dependent probability of being carrier and of the disease risk; Right: summary of results with the option to download a report in PDF format.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1526367179\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;Interface of the web-based tool for genetic counselling for the \u0026lt;em\u0026gt;C9orf72\u0026lt;\/em\u0026gt; \u0026lt;sup\u0026gt;RE\u0026lt;\/sup\u0026gt;-related ALS\/FTD diseases, avaiblable at https:\/\/lbbe-shiny.univ-lyon1.fr\/ftd-als\/. The application includes three panels. Left: input of consultand\u0026#x2019;s information; Centre: graphical visualization of the age-dependent probability of being carrier and of the disease risk; Right: summary of results with the option to download a report in PDF format.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 4:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022225\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 4:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F4.medium.gif\u0022 width=\u0022440\u0022 height=\u0022225\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F4.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 4:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/F4.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 4:\u003C\/span\u003E \u003Cp id=\u0022p-36\u0022 class=\u0022first-child\u0022\u003EInterface of the web-based tool for genetic counselling for the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E-related ALS\/FTD diseases, avaiblable at \u003Ca href=\u0022https:\/\/lbbe-shiny.univ-lyon1.fr\/ftd-als\/\u0022\u003Ehttps:\/\/lbbe-shiny.univ-lyon1.fr\/ftd-als\/\u003C\/a\u003E. The application includes three panels. Left: input of consultand\u2019s information; Centre: graphical visualization of the age-dependent probability of being carrier and of the disease risk; Right: summary of results with the option to download a report in PDF format.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-9\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussion\u003C\/h2\u003E\u003Cp id=\u0022p-37\u0022\u003ERisk assessment for diseases such as ALS\/FTD faces two levels of uncertainty: genetic randomness and extreme variability in the age of onset of symptoms. For this reason, it is mainly the clinical and psychological aspects that are emphasised in genetic counselling [\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-19-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E]. Most often, the only figures communicated to unaffected relatives of mutation carriers are the Mendelian-based risks of being carrier, \u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E., 50% for children and siblings, and 25% for grandchildren and niblings. However, these figures may differ significantly from the risk estimated when taking into account the age of the consultands. Since risk value is one of the key factors in the decision to get tested, it is important to provide the consultands with values that are as reliable as possible.\u003C\/p\u003E\u003Cp id=\u0022p-38\u0022\u003EIn this study, we addressed two questions psychologically crucial for unaffected relatives of a carrier of a deleterious mutation: given their age, what is their probability of being a carrier of the mutation, and what is their probability of developing the disease in the future? While there are quite a few articles on penetrance estimation from family history of diseases or from cohort analyses [\u003Ca id=\u0022xref-ref-22-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-16-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-6-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E], few studies formally address these issues [\u003Ca id=\u0022xref-ref-22-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-16-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-15-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E]. In addition, these formal studies, which have remained quite confidential, provide only partial and disparate answers and do not result in handy guides for genetic counselling.\u003C\/p\u003E\u003Cp id=\u0022p-39\u0022\u003EWe have formalised how to use the distribution of age at symptom onset of ALS\/FTD caused by \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E to estimate the risk of being a carrier and developing the disease for the children\/siblings and grandchildren\/niblings of a carrier, considering that penetrance tends toward either 1 or a limit. The eight equations we have established (two of which were proposed independently [\u003Ca id=\u0022xref-ref-15-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-22-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E]) have been implemented in an online simulation tool that allows the desired probabilities to be easily estimated.\u003C\/p\u003E\u003Cp id=\u0022p-40\u0022\u003EThe age-dependent penetrance values we used come from the large Murphy et al\u2019s cohort [\u003Ca id=\u0022xref-ref-14-6\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E]. We are aware that such empirical data suffers from various biases, such as the under-representation of aged people and the fact that the vast majority of patients are European, North American or Australian. However, moderate population-specific founder effects appear to exist for this mutation [\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E], and the penetrance estimates are roughly similar in other cohorts [\u003Ca id=\u0022xref-ref-10-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E], even in those including a fraction of patients from non-European origin [\u003Ca id=\u0022xref-ref-11-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-13-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E]. Various refinements for estimating the penetrance could be considered, such as taking into account the family history of the disease [\u003Ca id=\u0022xref-ref-22-5\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-20-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-6-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E] or the intra-family correlation for the onset of the disease [\u003Ca id=\u0022xref-ref-7-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-7\u0022\u003E7\u003C\/a\u003E], but we do not know whether this is worthwhile, given the uncertainty associated with the inevitable limited size of the families. In any case, if new approaches for penetrance estimate lead to more reliable values [\u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E], the simulator can and will be updated.\u003C\/p\u003E\u003Cp id=\u0022p-41\u0022\u003EThe risk estimates we found can be much lower than the Mendelian values classically given to the consultands. For example, even for children whose median age of symptom onset is 58 years, the probability of carrying the variant is 0.32 and not 0.5, and drops at 0.1 at 67-68 years. For grandchildren, taking parental status into account can make a big difference. For example, if the child is 70 and the grandchild 45, the probability of the grandchild carrying the mutation is only 0.025 (2.5% risk), whereas it is almost ten times higher (0.23) if parental status is ignored.\u003C\/p\u003E\u003Cp id=\u0022p-42\u0022\u003EThe existence of a fraction \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers is assumed [\u003Ca id=\u0022xref-ref-14-7\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-5-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-5\u0022\u003E5\u003C\/a\u003E], but its value is not known. Environmental, genetic (epistasis) and demographic (age at death) factors combine to make its estimate methodologically out of reach, or at best extremely imprecise, and non-penetrant carriers can have affected descendants. However, introducing \u003Cem\u003Ex\u003C\/em\u003E into the calculations makes it possible to analyse the impact of the presence of non-penetrant carriers on the calculated risks. For illustrative purpose, we set \u003Cem\u003Ex\u003C\/em\u003E at 0.2, the upper limit proposed by Murphy \u003Cem\u003Eet al\u003C\/em\u003E. [\u003Ca id=\u0022xref-ref-14-8\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E], but the whole range of risks can be explored by varying \u003Cem\u003Ex\u003C\/em\u003E. We believe that this may be of interest to counsellors and consultands.\u003C\/p\u003E\u003Cp id=\u0022p-43\u0022\u003EConsultands wishing to undergo presymptomatic testing must undergo a psychosocial assessment to verify their motivations to get tested and to determine whether they are ready to receive the results of their genetic test [\u003Ca id=\u0022xref-ref-19-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E]. In this context, we show that consultands whose age is beyond the median age of onset of symptoms have a risk of being carriers, and hence of being affected, markedly below the Mendelian proportions. Because many individuals express the sentiment that the anxiety of living with the unknown is worse than knowing whether or not they are at genetic risk [\u003Ca id=\u0022xref-ref-2-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E], we think that our results can represent a useful contribution to genetic counselling.\u003C\/p\u003E\u003Cp id=\u0022p-44\u0022\u003EFinally, we emphasize that our approach is valid for any other disease caused by an autosomal dominant mutation, provided empirical distributions of the age of onset of symptoms is available. This broad applicability makes our framework a generalizable tool for genetic counselling and risk assessment.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-10\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ECompeting interest\u003C\/h2\u003E\u003Cp id=\u0022p-45\u0022\u003EThe authors declare that they have no conflicts of interest.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-11\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData availability\u003C\/h2\u003E\u003Cp id=\u0022p-46\u0022\u003EAll the code used for data analysis, for figure preparation, and the source code of the online \u201cshiny\u201d application is available at \u003Ca href=\u0022https:\/\/github.com\/damiendevienne\/ftd-als\/\u0022\u003Ehttps:\/\/github.com\/damiendevienne\/ftd-als\/\u003C\/a\u003E\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-12\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EProbability of carrying the mutation for a child of the carrier\u003C\/h2\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-13\u0022\u003E\u003Ch3\u003ECase 1: The penetrance tends towards 1 with age\u003C\/h3\u003E\u003Cp id=\u0022p-48\u0022\u003EThe probability that an individual with one parent carrying the \u003Cem\u003EC9orf72\u003C\/em\u003E \u003Csup\u003ERE\u003C\/sup\u003E mutation is also a carrier is\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-1\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-6.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-6.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u003Cem\u003EM\u003C\/em\u003E stands for \u2018mutation\u2019. If we know that this individual has no symptoms of the disease at age \u003Cem\u003Et\u003C\/em\u003E, this probability writes:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-2\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-7.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-7.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E stands for \u2018unaffected at age \u003Cem\u003Et\u003C\/em\u003E\u2019. This probability can be estimated by applying the Bayes\u2019 theorem:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-3\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-8.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-8.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-1\u0022\u003E\u003Cli id=\u0022list-item-1\u0022\u003E\u003Cp id=\u0022p-49\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E (\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u003Cem\u003EM\u003C\/em\u003E) is the probability of not being affected at age \u003Cem\u003Et\u003C\/em\u003E despite being a carrier of the mutation. Note that 1 \u003Cem\u003E\u2212 P\u003C\/em\u003E (\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u003Cem\u003EM\u003C\/em\u003E) = \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u003Cem\u003EM\u003C\/em\u003E) is the age-related penetrance, which we will refer to as \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E hereafter. We assume here that there is no non-penetrant carriers, \u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E. that penetrance \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E tends towards 1 with age.\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-2\u0022\u003E\u003Cp id=\u0022p-50\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E (\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) = 1 \u003Cem\u003E\u2212 P\u003C\/em\u003E (\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) is the probability of not being affected at age \u003Cem\u003Et. P\u003C\/em\u003E (\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) is the product of the probability of carrying the mutation and of the penetrance: \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) = \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EM\u003C\/em\u003E)\u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E.\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-51\u0022\u003ETherefore \u003Ca id=\u0022xref-disp-formula-3-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-3\u0022\u003Eequation 1\u003C\/a\u003E can be rewritten in terms of age-related penetrance:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-4\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-9.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-9.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThis equation expresses the age-related probability for an unaffected child to carry the mutation (see also [\u003Ca id=\u0022xref-ref-22-6\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E]).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-14\u0022\u003E\u003Ch3\u003ECase 2: There is a proportion \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers\u003C\/h3\u003E\u003Cp id=\u0022p-52\u0022\u003EIt may happen that individuals carrying the mutation never get affected, regardless their age [\u003Ca id=\u0022xref-ref-10-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-11-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-14-9\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E, \u003Ca id=\u0022xref-ref-21-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E]. They are called non-penetrant carriers. Their presence alters both the probability of carrying the mutation for asymptomatic individuals and the probability of developing the disease.\u003C\/p\u003E\u003Cp id=\u0022p-53\u0022\u003ELet \u003Cem\u003Ex\u003C\/em\u003E the proportion of non-penetrant carriers. The probability that an unaffected individual of age \u003Cem\u003Et\u003C\/em\u003E is a carrier of the mutation writes (\u003Ca id=\u0022xref-disp-formula-3-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-3\u0022\u003Eequation 1\u003C\/a\u003E)\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-5\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-10.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-10.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-2\u0022\u003E\u003Cli id=\u0022list-item-3\u0022\u003E\u003Cp id=\u0022p-54\u0022\u003EThe index \u003Cem\u003Ex\u003C\/em\u003E of \u003Cem\u003EP\u003C\/em\u003E means \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0.\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-4\u0022\u003E\u003Cp id=\u0022p-55\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u003Cem\u003EM\u003C\/em\u003E) = 1 \u003Cem\u003E\u2212 P\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u003Cem\u003EM\u003C\/em\u003E). As only the fraction 1 \u003Cem\u003E\u2212 x\u003C\/em\u003E of the carriers can be affected, the penetrance \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-18\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-18.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-18.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E is equal to (1 \u003Cem\u003E\u2212 x\u003C\/em\u003E)\u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E. Because \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E tends towards 1 with age, \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-19\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-19.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-19.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E tends towards 1 \u003Cem\u003E\u2212 x\u003C\/em\u003E.\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-5\u0022\u003E\u003Cp id=\u0022p-56\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) = 1 \u003Cem\u003E\u2212 P\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E). The conditions for being affected are to be a carrier of the mutation and not to be a non-penetrant carrier. So \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) = \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EM\u003C\/em\u003E)(1 \u003Cem\u003E\u2212 x\u003C\/em\u003E)\u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E.\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-57\u0022\u003EIntroducing these terms in \u003Ca id=\u0022xref-disp-formula-5-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-5\u0022\u003Eequation 3\u003C\/a\u003E, we get\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-6\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-11.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-11.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThe derivative of \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EM\u003C\/em\u003E | \u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) with respect to \u003Cem\u003Ex\u003C\/em\u003E is positive, meaning that the probability of being carrier of the mutation when there is no symptom at age \u003Cem\u003Et\u003C\/em\u003E increases with \u003Cem\u003Ex\u003C\/em\u003E. This is due to the fact that a larger number of individuals may be asymptomatic despite being carriers. At the limit, if \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-20\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-20.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-20.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-15\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EProbability of developing the disease later in life for a child of the carrier\u003C\/h2\u003E\u003Cp id=\u0022p-58\u0022\u003EAn important issue for individuals at risk is not only the probability of carrying the mutation as seen above, but also the probability of developing the disease later in life, \u003Cem\u003Ee\u003C\/em\u003E.\u003Cem\u003Eg\u003C\/em\u003E. in the next \u003Cem\u003En\u003C\/em\u003E years.\u003C\/p\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-16\u0022\u003E\u003Ch3\u003ECase 1: The penetrance tends towards 1 with age\u003C\/h3\u003E\u003Cp id=\u0022p-59\u0022\u003EFor a nonaffected carrier of the mutation at age \u003Cem\u003Et\u003C\/em\u003E, the probability of being affected at age \u003Cem\u003Et\u003C\/em\u003E + \u003Cem\u003En\u003C\/em\u003E writes\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-7\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-12.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-12.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003EM\u003C\/em\u003E\u003C\/sub\u003E stands for the probability in the presence of the mutation. From Bayes\u2019 theorem, we have\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-8\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-13.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-13.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nBecause \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003EM\u003C\/em\u003E\u003C\/sub\u003E (\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E|\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E) = 1, it comes\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-9\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-14.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-14.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nSo (see also [\u003Ca id=\u0022xref-ref-15-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E]):\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-10\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-15.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-15.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThe probability of being affected is conditional to the presence of the mutation, the probability of which is \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EM\u003C\/em\u003E |\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E). Therefore, from \u003Ca id=\u0022xref-disp-formula-4-3\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-4\u0022\u003Eequations 2\u003C\/a\u003E and \u003Ca id=\u0022xref-disp-formula-10-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-10\u0022\u003E6\u003C\/a\u003E, we get\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-11\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-16.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-16.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nSo\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-12\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-17.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-17.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nAs \u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E tends towards 1 when \u003Cem\u003En\u003C\/em\u003E increases, this probability tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-21\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-21.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-21.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E \u003Cem\u003Ei\u003C\/em\u003E.\u003Cem\u003Ee\u003C\/em\u003E. towards \u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EM\u003C\/em\u003E |\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E), which is consistent: the probability of eventually being affected is equal to the probability of being a carrier of the mutation because the penetrance tends towards 1.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-17\u0022\u003E\u003Ch3\u003ECase 2: There is a proportion \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers\u003C\/h3\u003E\u003Cp id=\u0022p-60\u0022\u003EIf a proportion \u003Cem\u003Ex\u003C\/em\u003E of individuals are non-penetrant carriers, we have (see \u003Ca id=\u0022xref-disp-formula-9-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-9\u0022\u003Eequation 5\u003C\/a\u003E)\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-13\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-18.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-18.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003EMx\u003C\/em\u003E\u003C\/sub\u003E(\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E) is the probability of being unaffected at age \u003Cem\u003Et\u003C\/em\u003E + \u003Cem\u003En\u003C\/em\u003E. There are two ways to be unaffected: either being in the fraction \u003Cem\u003Ex\u003C\/em\u003E of the population or being in the fraction (1 \u003Cem\u003Ex\u003C\/em\u003E) while remaining unaffected. So\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-14\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-19.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-19.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nSimilarly\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-15\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-20.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-20.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nSo\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-16\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-21.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-21.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nTherefore\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-17\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-22.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-22.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\n\u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E tends towards 1 with age, so \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E (\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E| \u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-22\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-22.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-22.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, which is smaller than \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EM\u003C\/em\u003E | \u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E). Indeed, all the carriers will not become affected because \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-18\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EProbability of carrying the mutation for a grandchild of the carrier\u003C\/h2\u003E\u003Cp id=\u0022p-61\u0022\u003EThe developments above considered the case of the children of the individual carrying the variant. By applying the same approach, we can also compute these probabilities for the grandchildren of the carrier. The age of the child and the grandchildren are noted \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E1\u003C\/sub\u003E and \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E2\u003C\/sub\u003E, respectively.\u003C\/p\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-19\u0022\u003E\u003Ch3\u003ECase 1: The penetrance tends towards 1 with age\u003C\/h3\u003E\u003Cp id=\u0022p-62\u0022\u003EFollowing \u003Ca id=\u0022xref-disp-formula-3-3\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-3\u0022\u003Eequation 1\u003C\/a\u003E, the probability of carrying the mutation for a grandchild of the carrier is:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-18\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-23.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-23.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-3\u0022\u003E\u003Cli id=\u0022list-item-6\u0022\u003E\u003Cp id=\u0022p-63\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E (\u003Cem\u003EM\u003C\/em\u003E) is the probability that the grandchild has inherited the mutation from its parent.\u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-23\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-23.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-23.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-7\u0022\u003E\u003Cp id=\u0022p-64\u0022\u003E\u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-24\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-24.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-24.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-8\u0022\u003E\u003Cp id=\u0022p-65\u0022\u003E\u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-25\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-25.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-25.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the probability of being affected at age \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E2\u003C\/sub\u003E, is the product of the probability of carrying the mutation, \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-26\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-26.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-26.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, and of the penetrance \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-27\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-27.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-27.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. So \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-28\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-28.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-28.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E.\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-66\u0022\u003ETherefore\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-19\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-24.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-24.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThis probability decreases with both the age of the grandchild and the age of its at-risk parent.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-20\u0022\u003E\u003Ch3\u003ECase 2: There is a proportion \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers\u003C\/h3\u003E\u003Cp id=\u0022p-67\u0022\u003EWith a proportion \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers in the population, the probability of carrying the mutation for a grandchild is:\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-20\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-25.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-25.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nwhere\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-4\u0022\u003E\u003Cli id=\u0022list-item-9\u0022\u003E\u003Cp id=\u0022p-68\u0022\u003E\u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EM\u003C\/em\u003E) is the probability that the grandchild has inherited the mutation from its parent. From \u003Ca id=\u0022xref-disp-formula-6-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-6\u0022\u003Eequation 4\u003C\/a\u003E, we have: \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-29\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-29.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-29.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-10\u0022\u003E\u003Cp id=\u0022p-69\u0022\u003E\u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-30\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-30.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-30.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the probability of not being affected knowing that the mutation is present, is the sum of the probabilities of being non-penetrant, \u003Cem\u003Ex\u003C\/em\u003E, and of being penetrant and non affected \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-31\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-31.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-31.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. So \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-32\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-32.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-32.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E.\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-11\u0022\u003E\u003Cp id=\u0022p-70\u0022\u003E\u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-33\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-33.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-33.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, the probability of being affected at age \u003Cem\u003Et\u003C\/em\u003E\u003Csub\u003E2\u003C\/sub\u003E, is the product of three probabilities: (i) carrying the mutation, \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-34\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-34.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-34.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E; (ii) not to belong to the non-penetrant carriers, (1 \u003Cem\u003E\u2212 x\u003C\/em\u003E); (iii) being affected, which is penetrance \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-35\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-35.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-35.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. So\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-71\u0022\u003E\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-21\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-26.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-26.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nTherefore\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-22\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-27.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-27.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThis equation is similar to \u003Ca id=\u0022xref-disp-formula-19-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-19\u0022\u003Eequation 11\u003C\/a\u003E, with penetrances multiplied by (1 \u003Cem\u003E\u2212 x\u003C\/em\u003E).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-21\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EProbability of developing the disease later in life for a grandchild of the carrier\u003C\/h2\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-22\u0022\u003E\u003Ch3\u003ECase 1: The penetrance tends towards 1 with age\u003C\/h3\u003E\u003Cp id=\u0022p-72\u0022\u003EIf \u003Cem\u003Ex\u003C\/em\u003E = 0, we can use \u003Ca id=\u0022xref-disp-formula-11-1\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-11\u0022\u003Eequation 7\u003C\/a\u003E\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-23\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-28.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-28.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nand from \u003Ca id=\u0022xref-disp-formula-10-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-10\u0022\u003Eequations 6\u003C\/a\u003E and \u003Ca id=\u0022xref-disp-formula-19-3\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-19\u0022\u003E11\u003C\/a\u003E,\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-24\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-29.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-29.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nAs \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-36\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-36.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-36.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E tends towards 1 with \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-37\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-37.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-37.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-38\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-38.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-38.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. This is expected because in the absence of non-penetrant carriers, all carriers will eventually be affected.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-23\u0022\u003E\u003Ch3\u003ECase 2: There is a proportion \u003Cem\u003Ex\u003C\/em\u003E of non-penetrant carriers\u003C\/h3\u003E\u003Cp id=\u0022p-73\u0022\u003EIf a proportion \u003Cem\u003Ex\u003C\/em\u003E of individuals are non-penetrant carriers, we have (see \u003Ca id=\u0022xref-disp-formula-9-2\u0022 class=\u0022xref-disp-formula\u0022 href=\u0022#disp-formula-9\u0022\u003Eequation 5\u003C\/a\u003E)\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-25\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-30.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-30.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nWhere\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-26\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-31.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-31.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nAnd\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-27\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-32.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-32.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nSo\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-28\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-33.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-33.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nTherefore,\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-29\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-34.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-34.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\n\u003Cem\u003E\u03c0\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E tends towards 1 with age, so \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EA\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E+\u003Cem\u003En\u003C\/em\u003E\u003C\/sub\u003E|\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E) tends towards \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-39\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-39.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-39.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, which is smaller than \u003Cem\u003EP\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Ex\u003C\/em\u003E\u003C\/sub\u003E(\u003Cem\u003EM\u003C\/em\u003E|\u0100\u003Csub\u003E\u003Cem\u003Et\u003C\/em\u003E\u003C\/sub\u003E). Indeed, all the carriers will not become affected because \u003Cem\u003Ex \u0026gt;\u003C\/em\u003E 0.\u003C\/p\u003E\u003Cp id=\u0022p-74\u0022\u003EMaking \u003Cem\u003Ex\u003C\/em\u003E apparent, the function 16 writes\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-30\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-35.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-35.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThe second derivative of this function with respect to \u003Cem\u003Ex\u003C\/em\u003E is strictly negative in the interval considered, so the function has a maximum.\u003C\/p\u003E\u003Cp id=\u0022p-75\u0022\u003EThe first derivative is\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-31\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-36.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-36.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThe value of \u003Cem\u003Ex\u003C\/em\u003E that cancels out \u003Cem\u003Ef\u003C\/em\u003E \u003Csup\u003E\u003Cem\u003E\u2032\u003C\/em\u003E\u003C\/sup\u003E(\u003Cem\u003Ex\u003C\/em\u003E) is solution to the equation\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-32\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-37.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-37.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nor, after rearrangements\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-33\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-38.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-38.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThe solution to this quadradic equation for \u003Cem\u003Ex \u2208\u003C\/em\u003E [0, 1] is\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-34\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-39.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-39.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nThus, the fraction \u003Cem\u003Ex\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Em\u003C\/em\u003E\u003C\/sub\u003E of non-penetrant carriers for which the probability of declaring the disease in the next \u003Cem\u003En\u003C\/em\u003E years is maximum depends only on the age-dependent penetrance \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-40\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-40.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-40.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E of the child: the value of \u003Cem\u003En\u003C\/em\u003E and the age-dependent penetrance of the grandchild play no role.\u003C\/p\u003E\u003Cp id=\u0022p-76\u0022\u003EFrom the previous equation, we see that the maximum probability of reporting the disease is at \u003Cem\u003Ex\u003C\/em\u003E\u003Csub\u003E\u003Cem\u003Em\u003C\/em\u003E\u003C\/sub\u003E = 0 if the age-dependence penetrance of the child is\n\u003Cspan class=\u0022disp-formula\u0022 id=\u0022disp-formula-35\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-40.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/graphic-40.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\n\n\u003C\/span\u003E\nIf \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-41\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-41.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-41.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E. As \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-42\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-42.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-42.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E cannot exceed 1, the probability of reporting the disease increases up to \u003Cspan class=\u0022inline-formula\u0022 id=\u0022inline-formula-43\u0022\u003E\u003Cspan class=\u0022highwire-responsive-lazyload\u0022\u003E\u003Cimg src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 class=\u0022highwire-embed lazyload\u0022 alt=\u0022Embedded Image\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-43.gif\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-embed\u0022 alt=\u0022Embedded Image\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/highwire\/medrxiv\/early\/2025\/08\/12\/2025.08.08.25333050\/embed\/inline-graphic-43.gif\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/span\u003E, then tends to 0 as \u003Cem\u003Ex\u003C\/em\u003E tends towards 1.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section app\u0022 id=\u0022app-1\u0022\u003E\u003Ch2\u003EAppendix\u003C\/h2\u003E\u003Cp id=\u0022p-47\u0022\u003E\u003Cem\u003EThe following developments consider the case of unaffected children and grandchildren of a mutation carrier. They are equally valid in the case of siblings and niblings, respectively, because the probabilities of having inherited the mutation from the carrier are the same\u003C\/em\u003E, i.e. 0.5 \u003Cem\u003Eand\u003C\/em\u003E 0.25.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[1].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference [1] in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJon\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBeck\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003ELarge C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: The American Journal of Human Genetics\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E92\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2013\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EElsevier\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E345\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E353\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.cell.com\/ajhg\/fulltext\/S0002-9297(13)00043-8\u0022\u003Ehttps:\/\/www.cell.com\/ajhg\/fulltext\/S0002-9297(13)00043-8\u003C\/a\u003E (visited on 06\/11\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BThe%2BAmerican%2BJournal%2Bof%2BHuman%2BGenetics%26rft.volume%253D92%26rft.spage%253D345%26rft_id%253Dinfo%253Apmid%252F23434116%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=23434116\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[2].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference [2] in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.2\u0022 data-doi=\u002210.1212\/WNL.0000000000002773\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMichael\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBenatar\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EPresymptomatic ALS genetic counseling and testing: Experience and recommendations\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Neurology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E86\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E24\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EJune\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E2295\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2302\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E0028-3878, 1526-632X\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1212\/WNL.0000000000002773\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000002773\u0022\u003Ehttps:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000002773\u003C\/a\u003E (visited on 06\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BNeurology%26rft_id%253Dinfo%253Adoi%252F10.1212%252FWNL.0000000000002773%26rft_id%253Dinfo%253Apmid%252F27194384%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToibmV1cm9sb2d5IjtzOjU6InJlc2lkIjtzOjEwOiI4Ni8yNC8yMjk1IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjUvMDgvMTIvMjAyNS4wOC4wOC4yNTMzMzA1MC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[3].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-3-1\u0022 title=\u0022View reference [3] in text\u0022 id=\u0022ref-3\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.3\u0022 data-doi=\u002210.1097\/WCO.0b013e32835a3efb\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMarco\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003Evan Blitterswijk\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMariely\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDeJesus-Hernandez\u003C\/span\u003E\u003C\/span\u003E, and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERosa\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERademakers\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EHow do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?\u003C\/span\u003E\u201d \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIn: Current Opinion in Neurology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E25\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EDec\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E689\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E700\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1097\/WCO.0b013e32835a3efb\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCurrent%2Bopinion%2Bin%2Bneurology%26rft.stitle%253DCurr%2BOpin%2BNeurol%26rft.aulast%253Dvan%2BBlitterswijk%26rft.auinit1%253DM.%26rft.volume%253D25%26rft.issue%253D6%26rft.spage%253D689%26rft.epage%253D700%26rft.atitle%253DHow%2Bdo%2BC9ORF72%2Brepeat%2Bexpansions%2Bcause%2Bamyotrophic%2Blateral%2Bsclerosis%2Band%2Bfrontotemporal%2Bdementia%253A%2B%2Bcan%2Bwe%2Blearn%2Bfrom%2Bother%2Bnoncoding%2Brepeat%2Bexpansion%2Bdisorders%253F%26rft_id%253Dinfo%253Adoi%252F10.1097%252FWCO.0b013e32835a3efb%26rft_id%253Dinfo%253Apmid%252F23160421%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1097\/WCO.0b013e32835a3efb\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=23160421\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[4].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-4-1\u0022 title=\u0022View reference [4] in text\u0022 id=\u0022ref-4\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMariely\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDeJesus-Hernandez\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EExpanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Neuron\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E72\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2011\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EElsevier\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E245\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E256\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.cell.com\/neuron\/fulltext\/S0896-6273(11)00828-2?elq=18542bc8c8ff4a668c3d09a5c07f335a\u0022\u003Ehttps:\/\/www.cell.com\/neuron\/fulltext\/S0896-6273(11)00828-2?elq=18542bc8c8ff4a668c3d09a5c07f335a\u003C\/a\u003E (visited on 06\/30\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BNeuron%26rft.volume%253D72%26rft.spage%253D245%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[5].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-5-1\u0022 title=\u0022View reference [5] in text\u0022 id=\u0022ref-5\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.5\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAndrew GL\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDouglas\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDiana\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EBaralle\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EReduced penetrance of gene variants causing amyotrophic lateral sclerosis\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Journal of Medical Genetics\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E61\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EBMJ Publishing Group Ltd\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E294\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E297\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/jmg.bmj.com\/content\/61\/3\/294.abstract\u0022\u003Ehttps:\/\/jmg.bmj.com\/content\/61\/3\/294.abstract\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BJournal%2Bof%2BMedical%2BGenetics%26rft.volume%253D61%26rft.spage%253D294%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[6].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-6-1\u0022 title=\u0022View reference [6] in text\u0022 id=\u0022ref-6\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAndrew GL\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EDouglas\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EPersonalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIn: BMJ Neurology Open\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E6\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E), \u003Cspan class=\u0022cit-fpage\u0022\u003Ee000792\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11418571\/\u0022\u003Ehttps:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11418571\/\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BBMJ%2BNeurology%2BOpen%26rft.volume%253D6%26rft.spage%253De000792%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[7].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-7-1\u0022 title=\u0022View reference [7] in text\u0022 id=\u0022ref-7\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EFlorence\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EEsselin\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EClinical phenotype and inheritance in patients with C9orf72 hexanucleotide repeat expansion: results from a large French cohort\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Frontiers in Neuroscience\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E14\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EFrontiers Media SA\u003C\/span\u003E, p. \u003Cspan class=\u0022cit-fpage\u0022\u003E316\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.00316\/full\u0022\u003Ehttps:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.00316\/full\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BFrontiers%2Bin%2BNeuroscience%26rft.volume%253D14%26rft.spage%253D316%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[8].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference [8] in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.8\u0022 data-doi=\u002210.1007\/s00415-019-09363-4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECaroline V.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EGreaves\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJonathan D.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERohrer\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EAn update on genetic frontotemporal dementia\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: J Neurol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E266\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E2075\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2086\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E0340-5354, 1432-1459\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1007\/s00415-019-09363-4\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022http:\/\/link.springer.com\/10.1007\/s00415-019-09363-4\u0022\u003Ehttp:\/\/link.springer.com\/10.1007\/s00415-019-09363-4\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BJ%2BNeurol%26rft.volume%253D266%26rft.spage%253D2075%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs00415-019-09363-4%26rft_id%253Dinfo%253Apmid%252F31119452%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s00415-019-09363-4\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=31119452\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[9].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference [9] in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.9\u0022 data-doi=\u002210.1038\/s41591-024-03190-5\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKristina\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EIba\u00f1ez\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EIncreased frequency of repeat expansion mutations across different populations\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Nat Med\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E30\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E11\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E3357\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3368\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E1078-8956, 1546-170X\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41591-024-03190-5\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/www.nature.com\/articles\/s41591-024-03190-5\u0022\u003Ehttps:\/\/www.nature.com\/articles\/s41591-024-03190-5\u003C\/a\u003E (visited on 04\/23\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BNat%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41591-024-03190-5%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41591-024-03190-5\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[10].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-10-1\u0022 title=\u0022View reference [10] in text\u0022 id=\u0022ref-10\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.10\u0022 data-doi=\u002210.3233\/JAD-121456\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EIsabelle\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELe Ber\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EC9ORF72 Repeat Expansions in the Frontotemporal Dementias Spectrum of Diseases: A Flow-chart for Genetic Testing\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIn: JAD\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E34\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EJune\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2013\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E485\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E499\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E18758908, 13872877\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3233\/JAD-121456\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-121456\u0022\u003Ehttps:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-121456\u003C\/a\u003E (visited on 06\/11\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BJAD%26rft.volume%253D34%26rft.spage%253D485%26rft_id%253Dinfo%253Adoi%252F10.3233%252FJAD-121456%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3233\/JAD-121456\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[11].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-11-1\u0022 title=\u0022View reference [11] in text\u0022 id=\u0022ref-11\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.11\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EElisa\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMajounie\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EFrequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: The Lancet Neurology\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E11\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EElsevier\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E323\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E330\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS1474-4422(12)70043-1\/fulltext\u0022\u003Ehttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS1474-4422(12)70043-1\/fulltext\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BThe%2BLancet%2BNeurology%26rft.volume%253D11%26rft.spage%253D323%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[12].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference [12] in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.12\u0022 data-doi=\u002210.1111\/ene.14393\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMasrori\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVan Damme\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EAmyotrophic lateral sclerosis: a clinical review\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Euro J of Neurology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E27\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E10\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E1918\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1929\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E1351-5101, 1468-1331\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1111\/ene.14393\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.14393\u0022\u003Ehttps:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.14393\u003C\/a\u003E (visited on 06\/30\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BEuro%2BJ%2Bof%2BNeurology%26rft.volume%253D27%26rft.spage%253D1918%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fene.14393%26rft_id%253Dinfo%253Apmid%252F32526057%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/ene.14393\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32526057\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[13].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-13-1\u0022 title=\u0022View reference [13] in text\u0022 id=\u0022ref-13\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.13\u0022 data-doi=\u002210.1016\/S1474-4422(19)30394-1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKatrina M\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMoore\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EAge at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: The Lancet Neurology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E19\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E145\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E156\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E14744422\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/S1474-4422(19)30394-1\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442219303941\u0022\u003Ehttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442219303941\u003C\/a\u003E (visited on 04\/23\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BThe%2BLancet%2BNeurology%26rft.volume%253D19%26rft.spage%253D145%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1474-4422%252819%252930394-1%26rft_id%253Dinfo%253Apmid%252F31810826%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S1474-4422(19)30394-1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=31810826\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[14].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-14-1\u0022 title=\u0022View reference [14] in text\u0022 id=\u0022ref-14\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.14\u0022 data-doi=\u002210.1038\/s41598-017-02364-1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENatalie A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EMurphy\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EAge-related penetrance of the C9orf72 repeat expansion\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Sci Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E), p. \u003Cspan class=\u0022cit-fpage\u0022\u003E2116\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E2045-2322\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41598-017-02364-1\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/www.nature.com\/articles\/s41598-017-02364-1\u0022\u003Ehttps:\/\/www.nature.com\/articles\/s41598-017-02364-1\u003C\/a\u003E (visited on 04\/23\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BSci%2BRep%26rft.volume%253D7%26rft.spage%253D2116%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41598-017-02364-1%26rft_id%253Dinfo%253Apmid%252F28522837%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41598-017-02364-1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28522837\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[15].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference [15] in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.15\u0022 data-doi=\u002210.1007\/s10897-006-9040-9\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EShuji\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOgino\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EBayesian Risk Assessment in Genetic Testing for Autosomal Dominant Disorders with Age-Dependent Penetrance\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Journal of Genetic Counseling\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2007\u003C\/span\u003E). eprint: \u003Ca href=\u0022https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10897-006-9040-9\u0022\u003Ehttps:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10897-006-9040-9\u003C\/a\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E29\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E39\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E1573-3599\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1007\/s10897-006-9040-9\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1007\/s10897-006-9040-9\u0022\u003Ehttps:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1007\/s10897-006-9040-9\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BJournal%2Bof%2BGenetic%2BCounseling%26rft.volume%253D16%26rft.spage%253D29%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs10897-006-9040-9%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s10897-006-9040-9\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[16].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-16-1\u0022 title=\u0022View reference [16] in text\u0022 id=\u0022ref-16\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.16\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPaulo A.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOtto\u003C\/span\u003E\u003C\/span\u003E and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAndr\u00e9a RVR\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EHorimoto\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EPenetrance rate estimation in autosomal dominant conditions\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Genetics and molecular biology\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E35\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003ESciELO Brasil\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E583\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E588\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.scielo.br\/j\/gmb\/a\/NMwKBrQSTXg9sqLScMCxPZQ\/\u0022\u003Ehttps:\/\/www.scielo.br\/j\/gmb\/a\/NMwKBrQSTXg9sqLScMCxPZQ\/\u003C\/a\u003E (visited on 06\/11\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BGenetics%2Band%2Bmolecular%2Bbiology%26rft.volume%253D35%26rft.spage%253D583%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[17].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-17-1\u0022 title=\u0022View reference [17] in text\u0022 id=\u0022ref-17\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.17\u0022 data-doi=\u002210.1093\/brain\/awr179\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKatya\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERascovsky\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003ESensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Brain\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E134\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E9\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003ESept\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2011\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E2456\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2477\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E1460-2156, 0006-8950\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1093\/brain\/awr179\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awr179\u0022\u003Ehttps:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awr179\u003C\/a\u003E (visited on 04\/23\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BBrain%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fbrain%252Fawr179%26rft_id%253Dinfo%253Apmid%252F21810890%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/brain\/awr179\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=21810890\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000294959800007\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[18].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-18-1\u0022 title=\u0022View reference [18] in text\u0022 id=\u0022ref-18\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.18\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAlan E.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERenton\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Neuron\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E72\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2011\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EElsevier\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E257\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E268\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.cell.com\/neuron\/fulltext\/S0896-6273(11)00797-5\u0022\u003Ehttps:\/\/www.cell.com\/neuron\/fulltext\/S0896-6273(11)00797-5\u003C\/a\u003E (visited on 06\/30\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BNeuron%26rft.volume%253D72%26rft.spage%253D257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[19].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-19-1\u0022 title=\u0022View reference [19] in text\u0022 id=\u0022ref-19\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.19\u0022 data-doi=\u002210.1212\/NXG.0000000000000542\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJennifer\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERoggenbuck\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003E\u201cC9orf72 and the Care of the Patient With ALS or FTD: Progress and Recommendations After 10 Years\u201d. en\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EIn: Neurol Genet\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E), \u003Cspan class=\u0022cit-fpage\u0022\u003Ee542\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E2376-7839\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1212\/NXG.0000000000000542\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/www.neurology.org\/doi\/10.1212\/NXG.0000000000000542\u0022\u003Ehttps:\/\/www.neurology.org\/doi\/10.1212\/NXG.0000000000000542\u003C\/a\u003E (visited on 06\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNeurology%253A%2BGenetics%26rft.stitle%253DNeurol%2BGenet%26rft.aulast%253DRoggenbuck%26rft.auinit1%253DJ.%26rft.volume%253D7%26rft.issue%253D1%26rft.spage%253De542%26rft.epage%253De542%26rft.atitle%253DC9orf72%2Band%2Bthe%2BCare%2Bof%2Bthe%2BPatient%2BWith%2BALS%2Bor%2BFTD%253A%2BProgress%2Band%2BRecommendations%2BAfter%2B10%2BYears%26rft_id%253Dinfo%253Adoi%252F10.1212%252FNXG.0000000000000542%26rft_id%253Dinfo%253Apmid%252F33575483%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoibm5nIjtzOjU6InJlc2lkIjtzOjg6IjcvMS9lNTQyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjUvMDgvMTIvMjAyNS4wOC4wOC4yNTMzMzA1MC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[20].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference [20] in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.20\u0022 data-doi=\u002210.1186\/s13073-022-01142-7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EThomas P.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESpargo\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003ECalculating variant penetrance from family history of disease and average family size in population-scale data\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Genome Med\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E14\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EDec\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E), p. \u003Cspan class=\u0022cit-fpage\u0022\u003E141\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E1756-994X\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1186\/s13073-022-01142-7\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01142-7\u0022\u003Ehttps:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01142-7\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BGenome%2BMed%26rft.volume%253D14%26rft.spage%253D141%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs13073-022-01142-7%26rft_id%253Dinfo%253Apmid%252F36522764%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1186\/s13073-022-01142-7\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=36522764\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[21].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference [21] in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.08.08.25333050v1.21\u0022 data-doi=\u002210.1080\/21678421.2023.2272187\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EIris F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EVan Wijk\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-article-title\u0022\u003EAssessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion\u003C\/span\u003E\u201d. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003Een. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration\u003C\/abbr\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E25\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E1-2\u003C\/span\u003E (\u003Cspan class=\u0022cit-month\u0022\u003EJan\u003C\/span\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E), pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E188\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E196\u003C\/span\u003E. issn: \u003Cspan class=\u0022cit-issn\u0022\u003E2167-8421, 2167-9223\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi: \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1080\/21678421.2023.2272187\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E.\u003C\/span\u003E url: \u003Ca href=\u0022https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2023.2272187\u0022\u003Ehttps:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2023.2272187\u003C\/a\u003E (visited on 06\/12\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253Den.%2BIn%253A%2BAmyotrophic%2BLateral%2BSclerosis%2Band%2BFrontotemporal%2BDegeneration%26rft.volume%253D25%26rft.spage%253D188%26rft_id%253Dinfo%253Adoi%252F10.1080%252F21678421.2023.2272187%26rft_id%253Dinfo%253Apmid%252F37861203%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1080\/21678421.2023.2272187\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=37861203\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F08%2F12%2F2025.08.08.25333050.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[22].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference [22] in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.22\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EYuanjia\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERuth\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EOttman\u003C\/span\u003E\u003C\/span\u003E, and \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDaniel\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ERabinowitz\u003C\/span\u003E\u003C\/span\u003E. \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EA method for estimating penetrance from families sampled for linkage analysis\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Biometrics\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E62\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2006\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003EOxford University Press\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E1081\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1088\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/academic.oup.com\/biometrics\/article-abstract\/62\/4\/1081\/7324901\u0022\u003Ehttps:\/\/academic.oup.com\/biometrics\/article-abstract\/62\/4\/1081\/7324901\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BBiometrics%26rft.volume%253D62%26rft.spage%253D1081%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E[23].\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference [23] in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-book\u0022 id=\u0022cit-2025.08.08.25333050v1.23\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECaroline F.\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003EWright\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u201c\u003Cspan class=\u0022cit-chapter-title\u0022\u003EGuidance for estimating penetrance of monogenic disease-causing variants in population cohorts\u003C\/span\u003E\u201d. \u003Cspan class=\u0022cit-source\u0022\u003EIn: Nature Genetics\u003C\/span\u003E \u003Cspan class=\u0022cit-vol\u0022\u003E56\u003C\/span\u003E.\u003Cspan class=\u0022cit-issue\u0022\u003E9\u003C\/span\u003E (\u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E). Publisher: \u003Cspan class=\u0022cit-publ-name\u0022\u003ENature Publishing Group US New York\u003C\/span\u003E, pp. \u003Cspan class=\u0022cit-fpage\u0022\u003E1772\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1779\u003C\/span\u003E. url: \u003Ca href=\u0022https:\/\/www.nature.com\/articles\/s41588-024-01842-3\u0022\u003Ehttps:\/\/www.nature.com\/articles\/s41588-024-01842-3\u003C\/a\u003E (visited on 05\/25\/2025).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DIn%253A%2BNature%2BGenetics%26rft.volume%253D56%26rft.spage%253D1772%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}